Sequenom
Clinical trials sponsored by Sequenom, explained in plain language.
Now part of
Labcorp Holdings Inc.
LH
NYSE
A molecular diagnostics company known for prenatal testing, now part of Labcorp.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New blood test aims to sharpen prostate cancer detection Results expected Mar 2027 (estimated)
- Simple blood test may spot preeclampsia risk before symptoms appear Results expected Jun 2027 (estimated)